205 related articles for article (PubMed ID: 25369304)
1. Recent advances in the prevention of hepatocellular carcinoma recurrence.
Lu LC; Cheng AL; Poon RT
Semin Liver Dis; 2014 Nov; 34(4):427-34. PubMed ID: 25369304
[TBL] [Abstract][Full Text] [Related]
2. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
Xu J; Li J; Chen J; Liu ZJ
Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
[TBL] [Abstract][Full Text] [Related]
3. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
4. Postoperative therapy options for hepatocellular carcinoma.
Zhong JH; Ma L; Li LQ
Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
[TBL] [Abstract][Full Text] [Related]
5. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
6. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma.
Jiang E; Shangguan AJ; Chen S; Tang L; Zhao S; Yu Z
Cancer Lett; 2016 Sep; 379(2):262-7. PubMed ID: 26272181
[TBL] [Abstract][Full Text] [Related]
7. How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?
Wang CC; Kao JH
Expert Opin Pharmacother; 2016; 17(7):911-9. PubMed ID: 26831361
[TBL] [Abstract][Full Text] [Related]
8. Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma.
Qu LS; Jin F; Huang XW; Shen XZ
J Surg Oncol; 2010 Dec; 102(7):796-801. PubMed ID: 20886584
[TBL] [Abstract][Full Text] [Related]
9. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
Zhang ZY; Zhou ZQ; Zhou GW
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B viral load affects prognosis of hepatocellular carcinoma.
Yu SJ; Kim YJ
World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis.
Yuan P; Chen P; Qian Y
Can J Gastroenterol Hepatol; 2016; 2016():5234969. PubMed ID: 27446846
[TBL] [Abstract][Full Text] [Related]
12. Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma.
Ishikawa T
World J Gastroenterol; 2013 Oct; 19(37):6127-30. PubMed ID: 24115808
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy after curative treatment for hepatocellular carcinoma.
Kudo M
Oncology; 2011; 81 Suppl 1():50-5. PubMed ID: 22212936
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
Lao XM; Luo G; Ye LT; Luo C; Shi M; Wang D; Guo R; Chen M; Li S; Lin X; Yuan Y
Liver Int; 2013 Apr; 33(4):595-604. PubMed ID: 23402625
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for hepatocellular carcinoma after curative treatment.
Jeng WJ; Lin CC; Chen WT; Sheen IS; Lin CY; Lin SM
Dig Dis; 2014; 32(6):747-54. PubMed ID: 25376293
[TBL] [Abstract][Full Text] [Related]
16. Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.
Ishikawa T
World J Gastroenterol; 2013 Dec; 19(47):8861-6. PubMed ID: 24379608
[TBL] [Abstract][Full Text] [Related]
17. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
19. Effect of sustained virological response to interferon therapy for hepatitis C to the hepatectomy for primary hepatocellular carcinoma.
Tsujita E; Maeda T; Kayashima H; Harada N; Tsutsui S; Matsuda H; Kinjo N; Ikeda Y; Morita M; Ishida T
Hepatogastroenterology; 2015; 62(137):157-63. PubMed ID: 25911888
[TBL] [Abstract][Full Text] [Related]
20. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]